EVOFEM BIOSCIENCES, INC. Fair Value Adjustment of Warrants
EVOFEM BIOSCIENCES, INC. (EVFM) reported Fair Value Adjustment of Warrants of -$1.61 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-06-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-06-16
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2023-03-31 was -$1.61M, a 198.65% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2022-03-31 was $1.63M.
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for the quarter ending 2019-12-31 was $19.62M.
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2022 was -$82.47M, a 345.02% decline from fiscal 2021.
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2021 was $33.66M.
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2020 was -$27.28M, a 199.67% decline from fiscal 2019.
- EVOFEM BIOSCIENCES, INC. fair value adjustment of warrants for fiscal 2019 was $27.37M.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-03-31 | -$1.61M 10-Q · filed 2023-06-16 | |||||
| 2022-12-31 | -$82.47M 10-K · filed 2023-04-27 | |||||
| 2022-03-31 | $1.63M 10-Q · filed 2023-06-16 | |||||
| 2021-12-31 | $33.66M 10-K · filed 2023-04-27 | |||||
| 2020-12-31 | -$27.28M 10-K · filed 2022-03-10 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $19.62M derived: sum of 2 quarters · filed 2021-03-04 | $19.62M derived: sum of 3 quarters · filed 2021-03-04 | $22.93M derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-12-31 | $19.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $19.62M derived: sum of 2 quarters · filed 2021-03-04 | $22.93M derived: sum of 3 quarters · filed 2021-03-04 | $27.37M 10-K · filed 2021-03-04 | $7.75M 10-K · filed 2020-03-12 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | $3.31M derived: sum of 2 quarters · filed 2019-11-07 | $7.75M 10-Q · filed 2019-11-07 | $7.75M derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2019-06-30 | $3.31M 10-Q · filed 2019-08-06 | $7.75M 10-Q · filed 2019-08-06 | $7.75M derived: sum of 3 quarters · filed 2020-05-06 | $7.75M derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2019-06-05 | $3.30M 10-K · filed 2021-03-04 | |||||
| 2019-03-31 | $4.44M 10-Q · filed 2020-05-06 | $4.44M derived: sum of 2 quarters · filed 2020-05-06 | $4.44M derived: sum of 3 quarters · filed 2020-05-06 | $4.44M derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||||
| 2014-12-31 | -$568.97K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $1.48M derived: sum of 2 quarters · filed 2017-03-23 | $1.75M derived: sum of 3 quarters · filed 2017-03-23 | $860.84K 10-K · filed 2017-03-23 | ||
| 2014-09-30 | $2.04M 10-Q · filed 2015-11-12 | $2.32M derived: sum of 2 quarters · filed 2015-11-12 | $1.43M 10-Q · filed 2015-11-12 | |||
| 2014-06-30 | $271.35K 10-Q · filed 2015-08-13 | -$614.66K 10-Q · filed 2015-08-13 | ||||
| 2014-03-31 | -$886.01K 10-Q · filed 2015-05-14 | |||||
| 2013-12-31 | $490.80K 10-K · filed 2016-03-29 |